Suppr超能文献

特发性肺纤维化合并肺癌——综述

Idiopathic pulmonary fibrosis coexisting with lung cancer - a review.

作者信息

Zieliński Michał, Sitek Piotr, Ziora Dariusz

机构信息

Katedra i Klinika Chorób Płuc i Grużlicy, Wydział Lekarski z Oddziałem Lekarsko-dentystycznym w Zabrzu. Śląskiego Uniwersytetu Medycznego w Katowicach Department of Lung Diseases and Tuberculosis, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Poland.

出版信息

Adv Respir Med. 2018 Dec 30;86(6):ARM.a2018.0052. doi: 10.5603/ARM.a2018.0052.

Abstract

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease with poor prognosis. Although the underlying mechanisms are not fully understood, IPF is connected with lung cancer development, which farther worsens the prognosis. Various papers report IPF and cancer coexistence in 9.8% to even 82% of patients depending on observation period. Contrary to already established guidelines in the general population, there are no widely accepted recommendations on lung cancer treatment in IPF population. At the same time, various oncologic interventions can result in acute exacerbation of IPF. This paper tries to revise the available data on lung cancer in patients with preexisting IPF.

摘要

特发性肺纤维化(IPF)是一种预后较差的间质性肺病。尽管其潜在机制尚未完全明确,但IPF与肺癌的发生有关,这进一步恶化了预后。根据观察期不同,多篇论文报道IPF与癌症共存的患者比例在9.8%至82%之间。与普通人群中已确立的指南相反,目前尚无关于IPF患者肺癌治疗的广泛接受的建议。同时,各种肿瘤学干预措施可能导致IPF急性加重。本文试图对已有IPF患者肺癌的现有数据进行修订。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验